Skip to main content
. Author manuscript; available in PMC: 2012 Jan 17.
Published in final edited form as: Vaccine. 2010 Nov 21;29(4):754–762. doi: 10.1016/j.vaccine.2010.11.015

Table 3.

Prediction of population coverage.

Population/Area Class I
Coverage1 (%) Average Hit2 PC903
Australia 23.82 3.10 1.71
Europe 47.01 6.11 2.45
North Africa 0.00 0.00 0.00
North America 26.87 3.49 1.78
North-East Asia 21.40 2.78 1.65
Oceania 26.78 3.48 1.78
Other 40.36 5.25 2.18
South America 39.29 5.11 2.14
South-East Asia 12.35 1.61 1.48
Sub-Saharan Africa 18.27 2.37 1.59
Average 25.61 3.33 1.68
(Standard deviation) (13.31) (1.73) (0.63)
1

Projected population coverage (IEDB[www.iedb.org])

2

Average number of epitope hits/HLA combinations recognized by the population

3

Minimum number of epitope hits/HLA combinations recognized by 90% of the population